Skip to Content

Flucelvax

Licence status
Authorised: 15/11/2024
Active substances
A/(H1N1)-LIKE VIRUS ANTIGEN, A/(H3N2)-LIKE VIRUS ANTIGEN, B (Victoria lineage)-like virus antigen
Dosage Form
Suspension for injection in pre-filled syringe
Licence number
EU/1/24/1879/001-004
Licence holder
Seqirus Netherlands B.V.

Licence information

ATC code
J07BB02 influenza, inactivated, split virus or surface antigen
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to medical prescription. • Official batch release In accordance with Article 114 of Directive 2001/83/EC, the official batch release will be undertaken by a state laboratory or a laboratory designated for that purpose.
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
15/11/2024

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie